
Deleted Journal, Год журнала: 2025, Номер unknown, С. 200214 - 200214
Опубликована: Апрель 1, 2025
Язык: Английский
Deleted Journal, Год журнала: 2025, Номер unknown, С. 200214 - 200214
Опубликована: Апрель 1, 2025
Язык: Английский
Frontiers in Immunology, Год журнала: 2025, Номер 16
Опубликована: Март 12, 2025
Anti-NMDAR encephalitis is the most common autoimmune encephalitis. When first-line treatments fail, second-line therapies are employed. However, a standardized approach for treatment has yet to be established. We presented three cases of anti-NMDAR with seizures and psychosis as primary symptom. These patients showed inadequate response initial treatments, including intravenous immunoglobulin, methylprednisolone, plasma exchange. their symptoms were effectively controlled following subcutaneous administration ofatumumab. Previous studies have reported that twelve treated In this study, modified Rankin scale (mRS) scores at last follow-up all fifteen (including our cases) significantly lower compared peak disease (p < 0.001). Thirteen achieved full recovery. findings suggest CD20 monoclonal antibodies, particularly ofatumumab, may offer promising option
Язык: Английский
Процитировано
0Genes, Год журнала: 2025, Номер 16(4), С. 371 - 371
Опубликована: Март 24, 2025
Neuropsychiatric disorders are complex conditions with multifactorial etiologies, in which genetics play a pivotal role. Despite significant advancements psychiatric research, traditional treatment options remain largely symptomatic, focusing on clinical signs without fully addressing the underlying biological causes. However, recent developments precision medicine—an approach that tailors treatments based genetic, environmental, and lifestyle factors—hold great promise for transforming of these disorders. By identifying specific genetic markers understanding gene–environment interactions, medicine can offer more personalized effective treatments, leading to better patient outcomes. Our primary aim was explore how integrating data environmental factors could enhance neuropsychiatric such as schizophrenia, bipolar disorder, depression. The secondary examine potential pharmacogenomics gene therapy improving therapeutic strategies. results indicate while progress has been made, challenges remain, including complexity interactions need granular phenotypic data. In conclusion, revolutionize by providing individualized care considers makeup, influences, factors, paving way therapies improved
Язык: Английский
Процитировано
0Journal of Functional Foods, Год журнала: 2025, Номер 127, С. 106773 - 106773
Опубликована: Апрель 1, 2025
Язык: Английский
Процитировано
0Phytochemistry Reviews, Год журнала: 2025, Номер unknown
Опубликована: Апрель 7, 2025
Язык: Английский
Процитировано
0Deleted Journal, Год журнала: 2025, Номер unknown, С. 200214 - 200214
Опубликована: Апрель 1, 2025
Язык: Английский
Процитировано
0